Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.21.1
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 787,675 $ 749,458
Loans receivable, allowance for credit losses 88,392 90,426
Face amount of subordinated debentures 126,800 126,800
Unamortized discount and debt issuance costs $ 7,676 $ 7,828
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 33,585,181 33,560,801
Common stock outstanding (shares) 30,682,533 30,717,835
Accumulated other comprehensive (loss) income, tax (benefit) expense $ (2,268) $ 1,247
Treasury stock (shares) 2,902,648 2,842,966